Nogueira M - Search Results

1

Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort Study.

Torres T, Puig L, Vender R, Lynde C, Piaserico S, Carrascosa JM, Gisondi P, Daudén E, Conrad C, Mendes-Bastos P, Ferreira P, Leite L, Lu JD, Valerio J, Bruni M, Messina F, Nidegger A, Llamas-Velasco M, Del Alcazar E, Mufti A, White K, Caldarola G, Teixeira L, Romanelli P, Desai K, Gkalpakiotis S, Romanelli M, Yeung J, Nogueira M, Chiricozzi A. Torres T, et al. Among authors: nogueira m. Am J Clin Dermatol. 2021 Jul;22(4):567-579. doi: 10.1007/s40257-021-00598-4. Epub 2021 Mar 30. Am J Clin Dermatol. 2021. PMID: 33786754

2

Dupilumab for atopic dermatitis: evidence to date.

Rodrigues MA, Nogueira M, Torres T. Rodrigues MA, et al. Among authors: nogueira m. G Ital Dermatol Venereol. 2019 Dec;154(6):696-713. doi: 10.23736/S0392-0488.19.06417-4. Epub 2019 Jun 17. G Ital Dermatol Venereol. 2019. PMID: 31210470 Free article. Review.

3

Guselkumab for the treatment of psoriasis - evidence to date.

Nogueira M, Torres T. Nogueira M, et al. Drugs Context. 2019 Jul 9;8:212594. doi: 10.7573/dic.212594. eCollection 2019. Drugs Context. 2019. PMID: 31391856 Free PMC article. Review.

4

JAK Inhibitors for Treatment of Psoriasis: Focus on Selective TYK2 Inhibitors.

Nogueira M, Puig L, Torres T. Nogueira M, et al. Drugs. 2020 Mar;80(4):341-352. doi: 10.1007/s40265-020-01261-8. Drugs. 2020. PMID: 32020553 Review.

5

Management of psoriasis in pregnancy - a review of the evidence to date.

Ferreira C, Azevedo A, Nogueira M, Torres T. Ferreira C, et al. Among authors: nogueira m. Drugs Context. 2020 Mar 9;9:2019-11-6. doi: 10.7573/dic.2019-11-6. eCollection 2020. Drugs Context. 2020. PMID: 32201494 Free PMC article. Review.

6

Psoriasis, biologic therapy, and the pandemic of the 21st century.

Nogueira M, Vender R, Torres T. Nogueira M, et al. Drugs Context. 2020 May 14;9:2020-4-10. doi: 10.7573/dic.2020-4-10. eCollection 2020. Drugs Context. 2020. PMID: 32477419 Free PMC article.

7

Risk of tuberculosis reactivation with interleukin (IL)-17 and IL-23 inhibitors in psoriasis - time for a paradigm change.

Nogueira M, Warren RB, Torres T. Nogueira M, et al. J Eur Acad Dermatol Venereol. 2021 Apr;35(4):824-834. doi: 10.1111/jdv.16866. Epub 2020 Sep 1. J Eur Acad Dermatol Venereol. 2021. PMID: 32790003 Review.

8

Targeted Therapy for Pediatric Psoriasis.

Nogueira M, Paller AS, Torres T. Nogueira M, et al. Paediatr Drugs. 2021 May;23(3):203-212. doi: 10.1007/s40272-021-00443-5. Epub 2021 Apr 3. Paediatr Drugs. 2021. PMID: 33811318 Review.

9

Serum Levels of miR-146a in Patients with Psoriasis.

Leal B, Carvalho C, Ferreira AM, Nogueira M, Brás S, Silva BM, Selores M, Costa PP, Torres T. Leal B, et al. Among authors: nogueira m. Mol Diagn Ther. 2021 Jul;25(4):475-485. doi: 10.1007/s40291-021-00531-9. Epub 2021 May 2. Mol Diagn Ther. 2021. PMID: 33937970

10

A case of psoriasis and systemic lupus erythematous successfully treated with ustekinumab.

Nogueira M, Selores M, Torres T. Nogueira M, et al. Eur J Dermatol. 2021 Jun 1;31(3):429-431. doi: 10.1684/ejd.2021.4072. Eur J Dermatol. 2021. PMID: 34309535 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,241 results

Search Page